Show simple item record

dc.contributor.authorTuzlali, Sitki
dc.contributor.authorKeskin, Serkan
dc.contributor.authorBengisu, Ergin
dc.contributor.authorAydiner, Adnan
dc.date.accessioned2021-03-06T10:13:38Z
dc.date.available2021-03-06T10:13:38Z
dc.identifier.citationKeskin S., Bengisu E., Tuzlali S., Aydiner A., "Complete Response in a Patient with Granulosa Cell Tumor Treated with a Combination of Leuprolide and Tamoxifen", ONKOLOGIE, cilt.35, ss.451-453, 2012
dc.identifier.issn0378-584X
dc.identifier.othervv_1032021
dc.identifier.otherav_e95ed2eb-4fb6-4e56-8c5d-0cf8c7ff12a5
dc.identifier.urihttp://hdl.handle.net/20.500.12627/153331
dc.identifier.urihttps://doi.org/10.1159/000341078
dc.description.abstractBackground: Adult granulosa cell tumors (GCTs) are frequently hormonally active. Thus, hormonal agents have been evaluated for the treatment of advanced-stage or recurrent disease. Case Report: A 39-year-old patient presented with recurrent GCT. The patient received multiple treatment modalities, including surgery and 2 different chemotherapy regimens (cisplatin- and taxane-based). Abdominal computed tomography following these treatments showed local recurrence with multiple implants. The patient's inhibin B level increased to 187 pg/ml at this time. The patient was treated with leuprolide 11.25 mg every 3 months and tamoxifen 20 mg twice daily. The patient's inhibin B level began to decrease after 1 month and returned to normal after 4 months. The patient has been maintained on this treatment for 2 years and has tolerated the drugs well. Conclusion: The combination of leuprolide and tamoxifen had limited side effects in the presented patient and might be a viable treatment option for women with advanced-stage or recurrent adult ovarian GCTs.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleComplete Response in a Patient with Granulosa Cell Tumor Treated with a Combination of Leuprolide and Tamoxifen
dc.typeMakale
dc.relation.journalONKOLOGIE
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume35
dc.identifier.startpage451
dc.identifier.endpage453
dc.contributor.firstauthorID202866


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record